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Background: hOGG1 gene plays an important role in base excision 
repair system. It encodes a glycosylase that excises 8-hydroxyguanine 
(OH8Gua) from oxidatively-damaged nucleotides. OH8Gua is a major, 
highly mutagenic form of oxidative DNA damage induced by reactive 
free radicals present in tobacco smoke. Previous studies showed that the 
presence of homologous 326Cys hOGG1 gene variants was associated 
with both a lower hOGG1 repair activity and an increased risk of lung 
cancer (especially in heavy smokers). The aim of this study was to as-
sess the frequency of hOGG1 gene polymorphic variants in codon 326 
of exon 7 in NSCLC patients from Northern Poland and to assess the 
association between polymorphisms of hOGG1 gene and NSCLC risk. 
Methods: Study group included 162 patients (36 females and 126 
males), aged from 42 to 78 years (median 63) who underwent com-
plete pulmonary resection between 1996 and 2000. The control group 
consisted of 485 healthy subjects with no evidence of lung cancer or 
other neoplasm. hOGG1 Ser326Cys polymorphism was evaluated by 
ASA-PCR method in DNA isolated from lymphocytes. Samples were 
collected from patients before surgery and stored at -80ºC. 
Result: 326Cys carriers vs Ser/Ser variant were signiﬁcantly more 
common in the NSCLC group than in controls (41,4% vs 30,7% re-
spectively; p=0,0129). 
Conclusion: The presence of 326Cys variant is associated with an 
increased risk of lung cancer.
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Background: The XPD gene is involved in nucleotide excision repair 
of DNA by opening the DNA around the damage. It also takes part 
in the initiation of RNA transcription by RNA polymerase II. The 
Lys751Gln polymorphism of this gene is suspected to be a predisposing 
factor for NSCLC development as polymorphic variants of this gene 
have different repair efﬁciency. The aim of this study was to establish 
the frequencies of the polymorphic XPD Lys751Gln genotypes in Pol-
ish population and to assess the associated risk of NSCLC development.
Materials and Methods: The study group included 162 NSCLC pa-
tients (13 females and 149 males) who underwent curative pulmonary 
resection between the year 1996 and 2000. The control group included 
485 healthy subjects. DNA was extracted from frozen blood samples. 
XPD Lys751Gln polymorphism was evaluated by PCR-RFLP based 
methods. 
Results: The frequencies of XPD gene Lys751Gln genotypes (Lys/Lys, 
Lys/Gln, Gln/Gln) in NSCLC patients were 38.3%, 43.2% and 18.5%, 
respectively and 37.1%, 46.2% and 16.7% respectively in healthy 
controls. The proportion of Gln allele carriers vs Lys homozygotes was 
insigniﬁcantly lower in the NSCLC group than in controls (61.7% vs 
62.9%, p=0.86). 
Conclusions: These results indicate that XPD (gln751 variant) poly-
morphism does not carry increased risk of NSCLC development. 
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Objective: The mortality of lung cancer in Chinese women has 
increased signiﬁcantly in the past few decades despite the fact that 
women consumed fewer cigarettes. The most common pathological 
type of lung carcinoma in Chinese women is adenocarcinoma. Emerg-
ing evidence indicated that interaction between environmental and ge-
netic factors plays an important role. The purpose of this study was to 
investigate the expression of oncoproteins such as EGFR, VEGF, p53, 
P21and CerbB2 in resectable NSCLC. Furthermore, the relationship 
between expression of oncoproteins and gender, histological subtypes, 
and clinical outcome was analyzed. 
Methods: Immunohistochemical technique was used to detect the ex-
pressions of oncoproteins such as EGFR, VEGF, p53, P21and CerbB2 
in 261 completely resectable lung cancer patients. All the patients have 
received systematic examination to determine the clinical stage from 
2005.6 to 2005.12. The pathological type was conﬁrmed again. Immu-
nohistochemical staining was used to mark the pathological section and 
the expression of oncoproteins was deﬁned that staining cells greater 
than 10% of ﬁeld. Data regarding demographics, smoking, histology, 
family history of cancer, the symptoms in the diagnosis, clinic type, the 
diameter of lesions, stage, extent of operations and FVC, FEV1, MVV 
were obtained. SPSS 10.0 was used for statistical analysis; We analyze 
the clinical characteristics and the expression of oncoproteins of the 
subjects with descriptive statistics; X2 and independent samples test 
were tested the difference of gender, clinical feature; Logistic Regres-
sion models were used to analyze the correlations between expression 
of oncoproteins and clinical features. P<0.05 represents the difference 
is signiﬁcant.
Results: There were 136 men (51.7%) and 125 women (48.3%). 
Women were found to be more likely to have adenocarcinoma with 
peripheral type. However, squamous-carcinoma with more smok-
ing and advanced stage were predominant in men (p=0.000). The 
mean diameter of lesions was smaller in women than that in men 
(p=0.000). The mean data of FVC%, FEV1%, MVV% in women was 
better compared with that in men (p=0.000). The complete resec-
